478 related articles for article (PubMed ID: 32628911)
1. Effects of the COVID-19 pandemic on supply and use of blood for transfusion.
Stanworth SJ; New HV; Apelseth TO; Brunskill S; Cardigan R; Doree C; Germain M; Goldman M; Massey E; Prati D; Shehata N; So-Osman C; Thachil J
Lancet Haematol; 2020 Oct; 7(10):e756-e764. PubMed ID: 32628911
[TBL] [Abstract][Full Text] [Related]
2. "Because Every Drop Counts": Blood donation during the COVID-19 Pandemic.
Sahu KK; Raturi M; Siddiqui AD; Cerny J
Transfus Clin Biol; 2020 Aug; 27(3):105-108. PubMed ID: 32782213
[No Abstract] [Full Text] [Related]
3. The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region.
Al-Riyami AZ; Abdella YE; Badawi MA; Panchatcharam SM; Ghaleb Y; Maghsudlu M; Satti M; Lahjouji K; Merenkov Z; Adwan A; Feghali R; Gebril N; Hejress S; Hmida S; AlHumaidan H; Jamal D; Najjar O; Raouf M
Transfus Clin Biol; 2021 Feb; 28(1):16-24. PubMed ID: 33276150
[TBL] [Abstract][Full Text] [Related]
4. Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.
Ngo A; Masel D; Cahill C; Blumberg N; Refaai MA
Clin Lab Med; 2020 Dec; 40(4):587-601. PubMed ID: 33121624
[TBL] [Abstract][Full Text] [Related]
5. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.
Seghatchian J; Lanza F
Transfus Apher Sci; 2020 Jun; 59(3):102794. PubMed ID: 32448638
[No Abstract] [Full Text] [Related]
6. Deployment of convalescent plasma for the prevention and treatment of COVID-19.
Bloch EM; Shoham S; Casadevall A; Sachais BS; Shaz B; Winters JL; van Buskirk C; Grossman BJ; Joyner M; Henderson JP; Pekosz A; Lau B; Wesolowski A; Katz L; Shan H; Auwaerter PG; Thomas D; Sullivan DJ; Paneth N; Gehrie E; Spitalnik S; Hod EA; Pollack L; Nicholson WT; Pirofski LA; Bailey JA; Tobian AA
J Clin Invest; 2020 Jun; 130(6):2757-2765. PubMed ID: 32254064
[TBL] [Abstract][Full Text] [Related]
7. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
Farrugia A
Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
[No Abstract] [Full Text] [Related]
8. How did we rapidly implement a convalescent plasma program?
Budhai A; Wu AA; Hall L; Strauss D; Paradiso S; Alberigo J; Hillyer CD; Jett B; Tobian AAR; Bloch EM; Sachais BS; Shaz BH
Transfusion; 2020 Jul; 60(7):1348-1355. PubMed ID: 32449169
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19.
Franchini M; Del Fante C; Klersy C; Glingani C; Percivalle E; Baldanti F; Perotti C
Semin Thromb Hemost; 2020 Oct; 46(7):804-806. PubMed ID: 32512588
[No Abstract] [Full Text] [Related]
10. Treatment for emerging viruses: Convalescent plasma and COVID-19.
Brown BL; McCullough J
Transfus Apher Sci; 2020 Jun; 59(3):102790. PubMed ID: 32345485
[TBL] [Abstract][Full Text] [Related]
11. Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods.
Albahri OS; Al-Obaidi JR; Zaidan AA; Albahri AS; Zaidan BB; Salih MM; Qays A; Dawood KA; Mohammed RT; Abdulkareem KH; Aleesa AM; Alamoodi AH; Chyad MA; Zulkifli CZ
Comput Methods Programs Biomed; 2020 Nov; 196():105617. PubMed ID: 32593060
[TBL] [Abstract][Full Text] [Related]
12. The convalescent sera option for containing COVID-19.
Casadevall A; Pirofski LA
J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
[No Abstract] [Full Text] [Related]
13. Rolling with the changes.
Kaufman RM
Transfusion; 2020 May; 60(5):885. PubMed ID: 32323325
[No Abstract] [Full Text] [Related]
14. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
16. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
17. Patient blood management during the COVID-19 pandemic: a narrative review.
Baron DM; Franchini M; Goobie SM; Javidroozi M; Klein AA; Lasocki S; Liumbruno GM; Muñoz M; Shander A; Spahn DR; Zacharowski K; Meybohm P
Anaesthesia; 2020 Aug; 75(8):1105-1113. PubMed ID: 32339260
[TBL] [Abstract][Full Text] [Related]
18. The blood supply management amid the COVID-19 outbreak.
Raturi M; Kusum A
Transfus Clin Biol; 2020 Aug; 27(3):147-151. PubMed ID: 32386966
[TBL] [Abstract][Full Text] [Related]
19. Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic.
Grandone E; Mastroianno M; Caroli A; Ostuni A
Blood Transfus; 2020 May; 18(3):230-232. PubMed ID: 32453689
[No Abstract] [Full Text] [Related]
20. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
Accorsi P; Berti P; de Angelis V; De Silvestro G; Mascaretti L; Ostuni A;
Transfus Apher Sci; 2020 Aug; 59(4):102817. PubMed ID: 32532691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
